CONNECT WITH US
HealthTech

HealthTech

Anti-inflammatory peptide shows potential to prevent diabetes-related vision loss

Medical Xpress logo

Published on

Add as a preferred source on Google
Anti-inflammatory peptide shows potential to prevent diabetes-related vision loss

This article has been reviewed according to Science X's editorial process and policies. Editors have highlighted the following attributes while ensuring the content's credibility:

According to a study published in October in the journal Biomedicine & Pharmacotherapy, a molecule naturally produced by the human body may help protect vision against damage caused by high blood sugar. This finding paves the way for new strategies to prevent diabetic retinopathy. This complication affects more than 22% of people with diabetes worldwide. It occurs when high blood sugar levels cause inflammation and damage neurons and blood vessels in the retina, which can lead to permanent vision loss.

An international research project brought together scientists from the Federal University of São Paulo (UNIFESP) and São Paulo State University (UNESP) in Brazil and the University of Colorado Anschutz in the United States.

The group evaluated the Ac2-26 peptide, which is part of an anti-inflammatory protein called Annexin A1, in experimental models that simulate the human eye. The tests were conducted on cell cultures isolated from the retina and on three-dimensional structures that function as "mini-retinas" (organoids), both of which were derived from patients' stem cells.

In the experiments, the peptide acted on several fronts: it reduced inflammation, curbed oxidative stress and protected the function of mitochondria, which generate energy for cells. Together, these actions prevented the death of neurons exposed to high levels of glucose.

"We were able to demonstrate a protective effect on the retina and a potential new strategy for preventing diabetic retinopathy," notes Cristiane Gil, head of the Department of Morphology and Genetics at the School of Medicine (EPM) at UNIFESP and co-author of the article.


Source link

Disclaimer

We strive to uphold the highest ethical standards in all of our reporting and coverage. We TheMorningPulse.fyi want to be transparent with our readers about any potential conflicts of interest that may arise in our work. It's possible that some of the investors we feature may have connections to other businesses, including competitors or companies we write about. However, we want to assure our readers that this will not have any impact on the integrity or impartiality of our reporting. We are committed to delivering accurate, unbiased news and information to our audience, and we will continue to uphold our ethics and principles in all of our work. Thank you for your trust and support.